Market Report, "Molecular Detection Inc. - Product Pipeline Analysis, 2013 Update", Published
Molecular Detection Inc. (MDI) is medical device company. The company develops and markets diagnostic tools for detection of infectious diseases. It develops Detect-Ready molecular detection kits for a number of indications. The company's product is an rt-PCR-based diagnostic test for detecting MRSA, MSSA and methicillin-resistant non-S. aureus carriers using nasal samples. MDI develops kits for the detection of bloodstream MRSA markets its product through its brand name Detect-Ready. It develops detection kits for infection and bloodstream VR (vancomycin resistant) infection....
View full press release